Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doug Coyle

Showing results (141-150 of 186) with videos related to

Pageof 19
Sort By:
Ear and Hearing|April 23, 2025
Health Service Use in Children With Mild Bilateral and Unilateral Hearing LossElizabeth M Fitzpatrick, Eunjung Na, Marie Pigeon, et al.
Addiction (Abingdon, England)|December 16, 2017
Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMODManuel B Huber, Maximilian Präger, Kathryn Coyle, et al.
Diabetes/Metabolism Research and Reviews|December 24, 2021
Comparative efficacy and safety of antihyperglycemic drug classes for patients with type 2 diabetes following failure with metformin monotherapy: A systematic review and network meta-analysis of randomized controlled trialsHui Zheng, Ronald J Sigal, Doug Coyle, et al.
Journal of Midwifery & Women'S Health|September 11, 2018
Outcomes for the First Year of Ontario's Birth Center Demonstration ProjectAnn E Sprague, Dana Sidney, Elizabeth K Darling, et al.
BMJ Open|August 13, 2021
Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the development of an early economic evaluation model of chimeric antigen receptor T-cell therapyMackenzie Wilson, Kednapa Thavorn, Terry Hawrysh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist careEva Grunfeld, Mark N Levine, Jim A Julian, et al.
Pharmacoeconomics|September 7, 2022
Engaging Patients and Caregivers in an Early Health Economic Evaluation: Discerning Treatment Value Based on Lived ExperienceMackenzie Wilson, Kednapa Thavorn, Terry Hawrysh, et al.
JAMA|April 17, 2003
Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusionsPaul C Hébert, Dean Fergusson, Morris A Blajchman, et al.
American Heart Journal|February 28, 2016
Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trialVidal Essebag, Jeff S Healey, Felix Ayala-Paredes, et al.
Lung Cancer (Amsterdam, Netherlands)|August 22, 2013
Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)M Neil Reaume, Natasha B Leighl, Nicole Mittmann, et al.
Pageof 19

Showing results (141-150 of 186) with videos related to

Sort By:
Pageof 19
Ear and Hearing|April 23, 2025
Health Service Use in Children With Mild Bilateral and Unilateral Hearing LossElizabeth M Fitzpatrick, Eunjung Na, Marie Pigeon, et al.
Addiction (Abingdon, England)|December 16, 2017
Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMODManuel B Huber, Maximilian Präger, Kathryn Coyle, et al.
Diabetes/Metabolism Research and Reviews|December 24, 2021
Comparative efficacy and safety of antihyperglycemic drug classes for patients with type 2 diabetes following failure with metformin monotherapy: A systematic review and network meta-analysis of randomized controlled trialsHui Zheng, Ronald J Sigal, Doug Coyle, et al.
Journal of Midwifery & Women'S Health|September 11, 2018
Outcomes for the First Year of Ontario's Birth Center Demonstration ProjectAnn E Sprague, Dana Sidney, Elizabeth K Darling, et al.
BMJ Open|August 13, 2021
Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the development of an early economic evaluation model of chimeric antigen receptor T-cell therapyMackenzie Wilson, Kednapa Thavorn, Terry Hawrysh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist careEva Grunfeld, Mark N Levine, Jim A Julian, et al.
Pharmacoeconomics|September 7, 2022
Engaging Patients and Caregivers in an Early Health Economic Evaluation: Discerning Treatment Value Based on Lived ExperienceMackenzie Wilson, Kednapa Thavorn, Terry Hawrysh, et al.
JAMA|April 17, 2003
Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusionsPaul C Hébert, Dean Fergusson, Morris A Blajchman, et al.
American Heart Journal|February 28, 2016
Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trialVidal Essebag, Jeff S Healey, Felix Ayala-Paredes, et al.
Lung Cancer (Amsterdam, Netherlands)|August 22, 2013
Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)M Neil Reaume, Natasha B Leighl, Nicole Mittmann, et al.
Pageof 19